Navigation Links
ORTHOCON Announces Signing of Exclusive, Worldwide License Agreement With Bezwada Biomedical

IRVINGTON, N.Y., Aug. 31, 2011 /PRNewswire/ -- ORTHOCON, Inc., a privately-held therapeutic device company, today announced the signing of an exclusive, worldwide license agreement with Bezwada Biomedical to develop and commercialize Bezwada's technology for bone applications.  

Bezwada Biomedical is an innovation-driven company with proprietary technology platforms comprised of bioabsorbable and biocompatible polyurethanes and polyamides derived from hydrolyzable isocyanates. This technology can be utilized to create absorbable surgical devices for a variety of applications including structural support, fixation, and drug delivery, with the potential to address significant limitations of existing therapeutic modalities.

John J. Pacifico, President and Chief Executive Officer of ORTHOCON, commented, "This strategic partnership is another important milestone for ORTHOCON as it significantly enhances the company's technological capabilities and product pipeline." He added, "Bezwada Biomedical has invented new technology that clearly improves upon existing marketed products, and we are very pleased to be working with Dr. Bezwada and his team to develop and commercialize additional devices that address the needs of our surgeon customers."

"We are delighted to partner with ORTHOCON to develop and commercialize an important part of our technology for bone applications," stated Rao Bezwada, Ph.D., President and Chief Executive Officer of Bezwada Biomedical. "Given ORTHOCON's financial, technical, and commercial capabilities, we believe this is the right step to move our technology forward and we are thrilled to be working with the ORTHOCON team."

Richard Kronenthal, Ph.D., ORTHOCON's Founder, Chief Scientific Officer, and principal technology inventor, previously worked with Dr. Bezwada to develop several market-leading products. Commenting on this strategic partnership, Dr. Kronenthal stated, "Having known and worked with Dr. Bezwada for many years, and having assessed the advantages of his materials relative to other marketed technologies, I am enthusiastic about the new roads we are taking together to overcome important problems in orthopedic and other surgical specialties."  

ORTHOCON recently initiated development programs to advance the Bezwada technology towards commercialization.  

About Bezwada Biomedical

Bezwada Biomedical, established in 2003, is focused on novel and biocompatible materials applicable to unmet medical and surgical needs. The company, with specialized laboratory and manufacturing facilities in Hyderabad, India and Hillsborough, New Jersey, develops and produces novel polymers and precursors at experimental and commercial scales. For more information, please visit


Founded in 2005, ORTHOCON develops, manufactures, markets, and sells products that stop bone bleeding. In 2011, ORTHOCON announced the commercial introduction of its first 510(k) cleared product, Hemasorb Absorbable Bone Hemostat Matrix, and the 510(k) clearance of Hemasorb Apply, a proprietary applicator designed to deliver Hemasorb and other ORTHOCON products presently under development.  

ORTHOCON is funded by leading international venture capital investment firms. The company occupies 8,000 square feet at its state-of-the-art facility in Irvington, New York. For more information, please visit .

Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. ORTHOCON®, Inc. Receives 510(k) Clearance to Market HEMASORB Apply™
2. ORTHOCON® Receives CE Mark and Health Canada Medical Device License for HEMASORB®
3. ORTHOCON® Announces U.S. Market Launch of HEMASORB®
4. Caliper Life Sciences Announces IVIS Spectrum CT
5. Auxilium Pharmaceuticals Announces Investor Event to Occur at 2011 ASSH Meeting on September 9, 2011
6. BioDelivery Sciences Announces Upcoming Presentations at Three Investor Conferences
7. Elbit Imaging Announces Availability of Investor Relations Presentation - Analysis Sources and Uses
8. Elbit Imaging Ltd. Announces Second Quarter Results for 2011
9. Unilife Corporation Announces Preliminary Financial Results for the Fourth Quarter and Fiscal Year 2011
10. Pearl Therapeutics Announces Positive Results for Phase 2b Dose-Ranging Study of Formoterol MDI
11. Perrigo Announces FDA Final Approval for Ketoconazole Foam, 2%
Post Your Comments:
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced ... BRAHMS PCT (procalcitonin) assay as a dedicated testing solution ... this clearance, Roche is the first IVD company in ... sepsis risk assessment and management. PCT is ... levels in blood can aid clinicians in assessing the ...
(Date:6/23/2016)... -- , , , WHEN: , ... , , , LOCATION: , , , Online, with free ... EXPERT PANELISTS:  , , , Frost & Sullivan,s Global Vice President ... Industry Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... is witnessing an exceptional era. Several new demand spaces, such as ...
(Date:6/23/2016)... -- The vast majority of dialysis patients currently receive ... usually 3 times a week, with treatment times averaging ... equipment preparation and wait time.  This regimen can be ... who are elderly and frail.  Many elderly dialysis patients ... for some duration of time. Residents in ...
Breaking Medicine Technology:
(Date:6/26/2016)... Cary, North Carolina (PRWEB) , ... June 26, 2016 , ... ... the release of a new product that was developed to enhance the health of ... harvested for centuries. , The two main herbs in the PawPaws Cat Kidney ...
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... , ... June 25, 2016 , ... On Friday, June ... a Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments ... of the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott ...
(Date:6/24/2016)... , ... June 24, 2016 , ... Marcy was in a crisis. Her son James, ... out at his family verbally and physically. , “When something upset him, he couldn’t control ... use it. He would throw rocks at my other children and say he was going ...
(Date:6/24/2016)... ... ... Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair ... hour by 2020 and then adjusting it yearly to increase at the same rate as ... the wage floor does not erode again, and make future increases more predictable. , The ...
Breaking Medicine News(10 mins):